Cardiac insulin resistance in obesity involves defective insulin signaling at low concentrations, potentially driven by hyperphosphorylation of IRS-1, despite fully operative GLUT-4 translocation.
No takes yet. Share an insight, caveat, or question.
May inform obesity-related cardiomyopathy mechanisms; leaves open human therapeutic targeting of IRS-1 phosphorylation.
Kolter et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: